- Instruments (Cell Analyzers and Cell Sorters)
- Reagents & Consumables
- Software
- Accessories
- Services
Flow Cytometry Market size was valued at USD 4.5 billion in 2022 and is poised to grow at a significant CAGR of 8.4% from 2023-2029. Analyzing the expression of the intracellular molecule and cell surfaces is made more accessible by flow cytometry. It helps evaluate the purity of isolated subpopulations and describes and characterizes various types of cells in a heterogeneous cell population. The market is being driven by increased R&D efforts by many prominent players to create multicolor assays and cutting-edge analytical reagents. The need for flow cytometry has experienced rapid expansion due to the rising prevalence of chronic and infectious disorders, notably the COVID-19 outbreak. Following the explosion, many academic institutions and pharmaceutical firms are engaged in considerable research and development (R&D) initiatives to create novel vaccines and treatments. Due to this, there is an excellent need for flow cytometry applications in research. One of the main factors propelling the growth of the flow cytometry market is the expanding use of flow cytometry in clinical research.
Flow Cytometry Market Key Developments:
- For instance, in July 2021, Becton, Dickinson, and Company introduced a new digital marketplace for flow cytometry to offer consumers and their procurement teams an improved online purchase experience. The new BD Biosciences marketplace is an online destination for the most in-depth flow cytometry users because it provides the whole range of BD's research, clinical, and single-cell multi-omic products.
- Additionally, in October 2021, BD Life Sciences-Biosciences opened its second Center of Excellence (CoE) in flow cytometry for clinical research in India in association with Christian Medical College, Vellore. Such advancements increase the need for flow cytometry, fueling the market's expansion. Moreover, cancer and immunodeficiency are two conditions that are frequently diagnosed using flow cytometry. Additionally, the adverse effects of chemotherapy and radiation therapy in cancer treatment have led doctors to favor autologous and allogeneic stem cell therapies, positively influencing the development of this industry.
- In June 2020, Apogee Flow Systems Ltd. established Apogee Flow Asia Ltd. in Hong Kong, China. With this, Apogee Flow Systems expanded the presence of its flow cytometer solutions in the Asia Pacific market.
- In March 2021, Campus Bio Medico University and Teaching Hospital (Italy) has initiated a study, Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients.
Flow Cytometry Market Summary
Study Period
2023-29
Base Year
2022
CAGR
8.4%
Largest Market
North America
Fastest Growing Market
Asia-Pacific
Flow Cytometry Market Dynamics
A key market driver for flow cytometry is the rise in HIV diagnoses worldwide, and this is due to the direct use of flow cytometry technology in HIV diagnosis. To identify a cell, light scattering is used in flow cytometry. Depending on the type of scattering, these cells are given specific markers known as CDs (clusters of differentiation). The CDs for the HIV cell are known as CD4s, and flow cytometry can be used to detect HIV based on the quantity of CD4s present in a medium. The demand for diagnostic methods like flow cytometry is rising along with the global HIV population. However, the market's growth is hindered by a lack of knowledge about the potential advantages of flow cytometry techniques and the high cost of the necessary equipment.
North-America Got Significant Share
Flow Cytometry Market Regional Analysis
The flow cytometry market in North America is likely to hold a significant revenue share in 2022, and, in the following years, it is predicted to increase rapidly. This supremacy can be linked to the U.S.'s strong flow cytometry solution adoption rates, advanced healthcare infrastructure, and significant healthcare spending. Additionally, there is a substantial market for flow cytometry solutions due to the developed pharmaceutical industry, extensive research activities by research universities, and pharmaceutical businesses. Due to the automation of R&D operations and the rising prevalence of diseases like cancer and HIV, the Asia-Pacific region is expected to be the most attractive market over the projection period.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The flow cytometry market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Flow Cytometry Market Segmentation
By Product Type
By Technology
- Cell-Based
- Bead-Based
By Application
- Research
- Industrial
- Clinical
By End User
- Commercial Organizations
- Hospitals
- Academic Institutes
- Clinical Testing Labs
Frequently Asked Questions
The flow cytometry market is projected to expand at a CAGR of 8.4% during the forecast period.
Danaher Corporation, Becton, Dickinson and Company, Luminex Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc.
North America is the fastest-growing region for flow cytometry market
| 1. Executive Summary |
| 2. Global Flow Cytometry Market Introduction |
| 2.1. Global Flow Cytometry Market - Taxonomy |
| 2.2. Global Flow Cytometry Market - Definitions |
| 2.2.1. Product Type |
| 2.2.2. Technology |
| 2.2.3. Application |
| 2.2.4. End User |
| 2.2.5. Region |
| 3. Global Flow Cytometry Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Key Developments |
| 4. Global Flow Cytometry Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 4.1. Instruments |
| 4.1.1. Cell Analyzers and |
| 4.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.1.3. Market Opportunity Analysis |
| 4.1.2. Cell Sorters |
| 4.1.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.2.3. Market Opportunity Analysis |
| 4.2. Reagents & Consumables |
| 4.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.2.3. Market Opportunity Analysis |
| 4.3. Software |
| 4.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.3.3. Market Opportunity Analysis |
| 4.4. Accessories |
| 4.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.4.3. Market Opportunity Analysis |
| 4.5. Services |
| 4.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.5.3. Market Opportunity Analysis |
| 5. Global Flow Cytometry Market By Technology, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Cell-based |
| 5 1 1 Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Bead-based |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Flow Cytometry Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Research |
| 6.1.1. Pharmaceutical |
| 6.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.1.3. Market Opportunity Analysis |
| 6.1.2. Apoptosis |
| 6.1.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.2.3. Market Opportunity Analysis |
| 6.1.3. Cell Sorting |
| 6.1.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3.3. Market Opportunity Analysis |
| 6.1.4. Cell Cycle Analysis |
| 6.1.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.4.3. Market Opportunity Analysis |
| 6.1.5. Immunology |
| 6.1.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.5.3. Market Opportunity Analysis |
| 6.2. Industrial |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Clinical |
| 6.3.1. Cancer |
| 6.3.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.1.3. Market Opportunity Analysis |
| 6.3.2. Organ Transplantation |
| 6.3.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.2.3. Market Opportunity Analysis |
| 6.3.3. Immunodeficiency Hematology |
| 6.3.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3.3. Market Opportunity Analysis |
| 7. Global Flow Cytometry Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Commercial Organizations |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Hospitals |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Academic Institutes |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Clinical Testing Labs |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Flow Cytometry Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. MEA |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Flow Cytometry Market - Opportunity Analysis Index, By Technology, Product Type, Application, End User, , , , and Region, 2023-2029 |
| 9. North America Flow Cytometry Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Instruments |
| 9.1.1.1. Cell Analyzers and |
| 9.1.1.2. Cell Sorters |
| 9.1.2. Reagents & Consumables |
| 9.1.3. Software |
| 9.1.4. Accessories |
| 9.1.5. Services |
| 9.2. Technology Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Cell-based |
| 9.2.2. Bead-based |
| 9.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Research |
| 9.3.1.1. Pharmaceutical |
| 9.3.1.2. Apoptosis |
| 9.3.1.3. Cell Sorting |
| 9.3.1.4. Cell Cycle Analysis |
| 9.3.1.5. Immunology |
| 9.3.2. Industrial |
| 9.3.3. Clinical |
| 9.3.3.1. Cancer |
| 9.3.3.2. Organ Transplantation |
| 9.3.3.3. Immunodeficiency Hematology |
| 9.4. End User Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1. Commercial Organizations |
| 9.4.2. Hospitals |
| 9.4.3. Academic Institutes |
| 9.4.4. Clinical Testing Labs |
| 9.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.5.1. USA |
| 9.5.2. Canada |
| 10. Europe Flow Cytometry Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Instruments |
| 10.1.1.1. Cell Analyzers and |
| 10.1.1.2. Cell Sorters |
| 10.1.2. Reagents & Consumables |
| 10.1.3. Software |
| 10.1.4. Accessories |
| 10.1.5. Services |
| 10.2. Technology Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Cell-based |
| 10.2.2. Bead-based |
| 10.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Research |
| 10.3.1.1. Pharmaceutical |
| 10.3.1.2. Apoptosis |
| 10.3.1.3. Cell Sorting |
| 10.3.1.4. Cell Cycle Analysis |
| 10.3.1.5. Immunology |
| 10.3.2. Industrial |
| 10.3.3. Clinical |
| 10.3.3.1. Cancer |
| 10.3.3.2. Organ Transplantation |
| 10.3.3.3. Immunodeficiency Hematology |
| 10.4. End User Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. Commercial Organizations |
| 10.4.2. Hospitals |
| 10.4.3. Academic Institutes |
| 10.4.4. Clinical Testing Labs |
| 10.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1. Germany |
| 10.5.2. France |
| 10.5.3. Italy |
| 10.5.4. Spain |
| 10.5.5. UK |
| 10.5.6. Rest of Europe |
| 11. Asia Pacific Flow Cytometry Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Instruments |
| 11.1.1.1. Cell Analyzers and |
| 11.1.1.2. Cell Sorters |
| 11.1.2. Reagents & Consumables |
| 11.1.3. Software |
| 11.1.4. Accessories |
| 11.1.5. Services |
| 11.2. Technology Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Cell-based |
| 11.2.2. Bead-based |
| 11.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Research |
| 11.3.1.1. Pharmaceutical |
| 11.3.1.2. Apoptosis |
| 11.3.1.3. Cell Sorting |
| 11.3.1.4. Cell Cycle Analysis |
| 11.3.1.5. Immunology |
| 11.3.2. Industrial |
| 11.3.3. Clinical |
| 11.3.3.1. Cancer |
| 11.3.3.2. Organ Transplantation |
| 11.3.3.3. Immunodeficiency Hematology |
| 11.4. End User Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Commercial Organizations |
| 11.4.2. Hospitals |
| 11.4.3. Academic Institutes |
| 11.4.4. Clinical Testing Labs |
| 11.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1. China |
| 11.5.2. Japan |
| 11.5.3. South Korea |
| 11.5.4. India |
| 11.5.5. Rest of APAC |
| 12. Latin America Flow Cytometry Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Instruments |
| 12.1.1.1. Cell Analyzers and |
| 12.1.1.2. Cell Sorters |
| 12.1.2. Reagents & Consumables |
| 12.1.3. Software |
| 12.1.4. Accessories |
| 12.1.5. Services |
| 12.2. Technology Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Cell-based |
| 12.2.2. Bead-based |
| 12.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Research |
| 12.3.1.1. Pharmaceutical |
| 12.3.1.2. Apoptosis |
| 12.3.1.3. Cell Sorting |
| 12.3.1.4. Cell Cycle Analysis |
| 12.3.1.5. Immunology |
| 12.3.2. Industrial |
| 12.3.3. Clinical |
| 12.3.3.1. Cancer |
| 12.3.3.2. Organ Transplantation |
| 12.3.3.3. Immunodeficiency Hematology |
| 12.4. End User Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. Commercial Organizations |
| 12.4.2. Hospitals |
| 12.4.3. Academic Institutes |
| 12.4.4. Clinical Testing Labs |
| 12.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1. Brazil |
| 12.5.2. Mexico |
| 12.5.3. Argentina |
| 12.5.4. Rest of Latin America |
| 13. MEA Flow Cytometry Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Instruments |
| 13.1.1.1. Cell Analyzers and |
| 13.1.1.2. Cell Sorters |
| 13.1.2. Reagents & Consumables |
| 13.1.3. Software |
| 13.1.4. Accessories |
| 13.1.5. Services |
| 13.2. Technology Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Cell-based |
| 13.2.2. Bead-based |
| 13.3. Application Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Research |
| 13.3.1.1. Pharmaceutical |
| 13.3.1.2. Apoptosis |
| 13.3.1.3. Cell Sorting |
| 13.3.1.4. Cell Cycle Analysis |
| 13.3.1.5. Immunology |
| 13.3.2. Industrial |
| 13.3.3. Clinical |
| 13.3.3.1. Cancer |
| 13.3.3.2. Organ Transplantation |
| 13.3.3.3. Immunodeficiency Hematology |
| 13.4. End User Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Commercial Organizations |
| 13.4.2. Hospitals |
| 13.4.3. Academic Institutes |
| 13.4.4. Clinical Testing Labs |
| 13.5. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1. GCC Countries |
| 13.5.2. South Africa |
| 13.5.3. Rest of MEA |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Danaher Corporation |
| 14.2.2. Becton |
| 14.2.3. Dickinson and Company |
| 14.2.4. Luminex Corporation |
| 14.2.5. Agilent Technologies, Inc. |
| 14.2.6. Bio-Rad Laboratories, Inc. |
| 14.2.7. Miltenyi Biotec |
| 14.2.8. Sysmex Corporation |
| 14.2.9. Stratedigm, Inc. |
| 14.2.10. Apogee Flow Systems Ltd. |
| 14.2.11. Sony Biotechnology, Inc. |
| 14.2.12. Thermo Fisher Scientific, Inc. |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
- Danaher Corporation
- Becton
- Dickinson and Company
- Luminex Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Miltenyi Biotec
- Sysmex Corporation
- Stratedigm, Inc.
- Apogee Flow Systems Ltd.
- Sony Biotechnology, Inc.
- Thermo Fisher Scientific, Inc.